Physician profile
Abigail Talbot
NPI 1104269745
$2,946.51
in general payments reported to CMS, 2019-2025
34 companies · $501 in 2025
The $501 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $285 · 2021: $486 · 2022: $508 · 2023: $474 · 2024: $336 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,267 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.41 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $562.01 | 2020-2025 | Injectafer |
| Abbvie INC. | $459.06 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Channel Medsystems, INC. | $220.45 | 2022-2023 | |
| Hologic Sales and Service, LLC | $150.57 | 2019-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Acessa Provu System |
| Exeltis, USA INC. | $131.83 | 2021-2025 | Slynd |
| Therapeuticsmd, INC. | $105.89 | 2019-2022 | |
| Shield Therapeutics INC | $105.56 | 2023-2025 | Accrufer |
| Novo Nordisk INC | $95.88 | 2021-2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $94.36 | 2022-2025 | |
| Pfizer INC. | $83.17 | 2020-2023 | |
| Amgen INC. | $82.04 | 2019-2021 | |
| Biogen, INC. | $74.87 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $68.35 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $67.14 | 2024 | Exparel |
| Organon LLC | $61.52 | 2024-2025 | Nexplanon, Jada System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $61.31 | 2021-2025 | |
| Mylan Pharmaceuticals INC. | $47.90 | 2019-2021 | |
| Astellas Pharma US INC | $47.17 | 2023-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Agile Therapeutics, INC. | $41.80 | 2021 | |
| Minerva Surgical, INC | $40.02 | 2021-2022 | |
| Evofem Biosciences, INC. | $38.88 | 2021 | |
| Lupin INC. | $34.00 | 2019-2020 | |
| Coopersurgical, INC. | $28.46 | 2020-2022 | |
| Medtronic, INC. | $28.23 | 2023 | Truclear |
| Virtus Pharmaceuticals LLC | $27.68 | 2021-2022 | |
| Millicent US INC | $26.16 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Seqirus USA INC | $23.77 | 2024 | Flucelvax |
| Amag Pharmaceuticals, INC. | $22.74 | 2019 | |
| Roche Diagnostics Corporation | $18.45 | 2019 | |
| Scynexis, INC. | $17.04 | 2022 | |
| Myovant Sciences INC. | $13.24 | 2021 | |
| Boston Scientific Corporation | $12.73 | 2019 | |
| Allergan, INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Talbot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.